Hipec Cancer Therapy: How It Works, Results and What to Expect

HIPEC cancer therapy is a specialized treatment that pairs cytoreductive surgery, which removes visible tumors in the abdomen, with heated chemotherapy circulated directly inside the abdominal cavity. It may be considered for carefully selected people with cancer affecting the peritoneum, the lining of the abdomen, and requires assessment by an experienced multidisciplinary cancer team.

Overview: What Is HIPEC Cancer Therapy?

HIPEC cancer therapy, short for hyperthermic intraperitoneal chemotherapy, is a treatment used for selected cancers that have spread within the peritoneal cavity. The peritoneum is the thin lining around the abdominal organs. HIPEC is given during a major operation, after surgeons have removed as much visible cancer as possible; this surgical part is called cytoreductive surgery.

During HIPEC, a chemotherapy solution is warmed and circulated through the abdomen for a controlled period before the incision is closed. Heating may help the medicine work against cancer cells on peritoneal surfaces, while local delivery allows a high concentration of chemotherapy in the abdominal cavity. The treatment is not the same as standard intravenous chemotherapy, and it is usually part of a broader, individualized cancer plan.

HIPEC is most often discussed for certain appendiceal, colorectal, ovarian, mesothelioma, and other peritoneal surface cancers. Its role differs by diagnosis and is still evolving in some settings. A specialist team considers the available evidence, the person’s goals, and alternative options before recommending it.

How HIPEC Works With Cytoreductive Surgery

The main purpose of cytoreductive surgery is to remove visible cancer deposits from the peritoneum and, when needed, affected organs or portions of organs. The amount and location of disease influence whether this can be done safely. HIPEC is intended to treat microscopic cancer cells that may remain on abdominal surfaces after surgery but cannot be seen or removed directly.

Once cytoreduction is complete, the surgical team places tubes into the abdomen and circulates a heated chemotherapy solution using a specialized perfusion system. The temperature, drug choice, duration, and technique are planned by the treating team and may vary according to the cancer type and the patient’s condition. The solution is then drained, the abdomen is rinsed when appropriate, and the operation is completed.

Because this is a complex treatment, planning commonly involves surgical oncologists, medical oncologists, anesthesiologists, radiologists, pathologists, specialized nurses, nutrition professionals, and rehabilitation teams. The primary procedure is HIPEC hyperthermic intraperitoneal chemotherapy, which should be performed in a center with appropriate surgical and critical-care expertise.

Who May Be a Candidate for HIPEC?

HIPEC is not appropriate for all cancers in the abdomen or for all people with peritoneal spread. Candidates are assessed individually. In general, clinicians look at the primary cancer type, the volume and pattern of disease within the abdomen, whether disease is present outside the peritoneal cavity, previous treatments, and whether surgeons believe visible disease can be removed to an acceptable extent.

General health also matters. The team evaluates heart, lung, kidney, liver, nutritional status, physical function, and the ability to recover from a long operation. Imaging scans, blood tests, pathology review, and sometimes diagnostic laparoscopy may be used to estimate the extent of disease and clarify whether surgery is feasible.

For some people, systemic chemotherapy, targeted therapy, immunotherapy, standard surgery, symptom-focused care, or clinical trials may be more suitable. A second opinion from a peritoneal surface malignancy team can help a person understand whether HIPEC offers a reasonable balance of potential benefit and risk for their situation.

• Potentially favorable factors include disease confined mainly to the peritoneal cavity and the possibility of substantial tumor removal.
• Factors that may limit suitability include extensive disease that cannot be safely removed, serious medical conditions, or cancer that is progressing rapidly despite treatment.
• Eligibility decisions should be based on individualized review rather than cancer stage alone.

What Happens Before, During, and After the Procedure?

Before surgery, the care team explains the proposed operation, expected recovery, possible need for organ resection, and risks. Patients may have imaging, laboratory testing, anesthesia assessment, medication review, nutritional support, and advice about movement, breathing exercises, and smoking cessation. Depending on the cancer, chemotherapy before surgery may be part of the treatment plan.

On the day of surgery, the patient receives general anesthesia. The surgical phase can be lengthy because it may include removal of tumor deposits from several abdominal areas. After cytoreduction, the heated chemotherapy is circulated in the abdomen. The patient is closely monitored throughout the operation and afterwards, sometimes initially in a higher-acuity or intensive care setting.

Hospital stay varies with the extent of surgery, complications, and recovery of bowel function. Early care focuses on pain control, breathing exercises, blood-clot prevention, wound care, nutrition, and gradual return to walking. Some patients temporarily need intravenous fluids, drains, a urinary catheter, or nutritional support while the digestive system recovers.

What Is Life Like After HIPEC Surgery?

Life after HIPEC surgery often involves a gradual recovery rather than an immediate return to usual activities. Tiredness, reduced appetite, abdominal discomfort, changes in bowel habits, and emotional ups and downs are common in the early weeks. Many people need help at home initially and benefit from a paced plan for walking, nutrition, sleep, and activity.

Recovery time differs widely because the procedure may involve extensive abdominal surgery. People are usually advised to avoid heavy lifting and strenuous activity until their surgical team confirms that healing is progressing well. Follow-up appointments monitor the incision, nutrition, blood counts, kidney function when relevant, and any symptoms that could indicate infection or other complications.

Longer term, some people return to many of their usual routines, while others have persistent digestive changes, fatigue, adhesions, or effects related to organ removal. Dietitian guidance, physiotherapy, and psychological support can be valuable. It is important to discuss practical concerns, including work, travel, fertility, sexuality, and body image, with the care team before and after treatment.

Benefits, Risks, and Expected Results

For appropriately selected patients, HIPEC combined with cytoreductive surgery may help control cancer within the abdomen and, in some cancer types, may improve outcomes compared with approaches that do not include this strategy. Its possible benefits must be considered alongside the substantial demands of major surgery. HIPEC is not a guaranteed cure and does not replace ongoing oncology care.

Potential complications include bleeding, infection, blood clots, wound problems, bowel leakage or obstruction, delayed bowel function, fluid and electrolyte changes, kidney injury, and chemotherapy-related effects. The risk depends on the extent of surgery, the chemotherapy used, pre-existing health conditions, and the amount of cancer present. Some complications require further procedures or a longer hospital stay.

What is the survival rate for patients who received HIPEC therapy? There is no single survival rate that applies to everyone who receives HIPEC. Reported outcomes vary greatly by the primary cancer, tumor grade and biology, disease burden, completeness of tumor removal, prior treatment, and the person’s overall health. A treating specialist can place published outcome data in context for a specific diagnosis, but individual results cannot be predicted from averages alone.

Can cancer come back after HIPEC surgery? Yes. Cancer can recur after HIPEC surgery, either in the abdomen or elsewhere in the body. Regular surveillance with clinical review, imaging, and laboratory tests when appropriate helps the team identify recurrence and discuss options such as systemic treatment, further surgery in selected cases, or supportive care.

Is HIPEC Worth It?

Is HIPEC worth it? Whether HIPEC is worthwhile is a personal and clinical decision, not a question with one universal answer. For a carefully selected patient whose disease can be effectively reduced with surgery, the potential for improved disease control may justify the intensity of treatment. For another person, the likely risks, recovery demands, or expected benefit may make a different approach more appropriate.

A useful discussion with the cancer team includes the treatment goal, expected benefit for that particular cancer, alternatives, possible effects on daily life, the chance of complications, and what follow-up treatment may still be needed. Patients may wish to bring a family member or caregiver to the consultation and write down questions in advance.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals assess and treat eligible international patients with complex abdominal cancers, including those being considered for HIPEC. A clear, shared decision based on medical evidence and the patient’s priorities is central to planning care.

When to Seek Medical Care

Anyone diagnosed with a cancer that may have spread to the peritoneum should discuss treatment options promptly with their oncology team. A referral to a center experienced in cytoreductive surgery and HIPEC may be appropriate when the cancer type and distribution suggest this approach could be considered. Seeking an expert opinion does not commit a person to surgery.

After HIPEC or any major abdominal operation, urgent medical advice is important for fever, worsening abdominal pain, persistent vomiting, inability to keep fluids down, increasing abdominal swelling, shortness of breath, chest pain, new leg swelling, heavy wound drainage, or redness spreading around an incision. These symptoms do not always mean a serious complication, but they should be assessed without delay.

People should also contact their care team about ongoing poor appetite, dehydration, severe diarrhea or constipation, uncontrolled pain, low mood, or difficulty coping during recovery. Timely support can help prevent complications and improve comfort, nutrition, and rehabilitation.

Frequently asked questions

Is HIPEC the same as chemotherapy?

HIPEC uses chemotherapy, but it is different from standard chemotherapy given through a vein or by mouth. It is delivered directly into the abdominal cavity during surgery and is usually combined with cytoreductive surgery. Some patients may receive both HIPEC and systemic chemotherapy at different stages of care.

How long does HIPEC surgery take?

The duration varies considerably because the surgical removal of visible cancer may be extensive. The HIPEC circulation is only one portion of the operation. The treating surgical team can provide a more individualized estimate after reviewing scans and the planned procedure.

Is HIPEC painful?

The patient is under general anesthesia during HIPEC surgery and does not feel the procedure itself. Pain and discomfort can occur during recovery from the abdominal operation, but the hospital team uses a tailored pain-management plan. Pain should be reported so treatment can be adjusted safely.

Can HIPEC be repeated?

In selected circumstances, repeat cytoreductive surgery and HIPEC may be considered if cancer recurs in the abdomen. This depends on the cancer type, location and extent of recurrence, prior treatment, time since surgery, and overall health. Repeat surgery is not suitable for everyone.

Will HIPEC cause hair loss?

Hair loss is generally less common with HIPEC alone than with many forms of systemic chemotherapy because the medicine is delivered locally. However, some chemotherapy can still be absorbed into the bloodstream, and side effects depend on the drug used. A medical oncologist can explain the expected effects of the planned regimen.

What follow-up is needed after HIPEC?

Follow-up usually includes regular visits with the surgical and oncology teams, along with imaging and blood tests when clinically appropriate. The schedule is individualized according to the cancer type and treatment plan. Follow-up also addresses nutrition, physical recovery, symptoms, and plans for any additional therapy.

References

• National Cancer Institute
• American Cancer Society
• European Society for Medical Oncology
• American Society of Clinical Oncology
• National Comprehensive Cancer Network

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.